EndoChoice, De Lage Landen Financial Services collaborate, Spring Bank Pharmaceutical appoints CMO — 4 GI/endoscopy company key notes

Written by Anuja Vaidya | November 11, 2015 | Print  |

Here are four news updates on key gastroenterology and endoscopy companies.

EndoChoice has a consensus revenue estimate of $74.51 million for fiscal year 2015.

EndoChoice is collaborating with De Lage Landen Financial Services to create a new financing option for customers interested in its Fuse Endoscopy system.

Clinical-stage biopharmaceutical company Spring Bank Pharmaceutical appointed Nezam Afdhal, MD, CMO.

Olympus introduced its CleverCut3V Distal Wireguided sphincterotome.

More articles on GI/endoscopy:
Exact Sciences to open biotech campus & more – 3 GI company key notes
CMS cuts to colonoscopy reimbursement finalized: 3 things to know
6 recent must-reads on CRC screening & treatments

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.